The EFSA Journal (2005) 274, 1-10
|
|
- Archibald Carr
- 5 years ago
- Views:
Transcription
1 The EFSA Journal (2005) 274, 1-10 Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in ontact with Food on a request from the ommission related to Epoxy Phenolic Novolac Resins (NOGE) Question N EFSA-Q Adopted on 6 October 2005 SUMMARY EFSA is asked to carry out risk assessments for substances intended for use in materials in contact with food, according to Regulation (E) No. 1935/2004 of the European Parliament and of the ouncil of 27 October 2004 on materials and articles intended to come into contact with food. In particular, EFSA is asked to advise the ommission on the implications for human health of the use of Epoxy Phenolic Novolac Resins (Novolac Glycidyl Ether, NOGE) as a starting substance in epoxy resins used for heavy duty coatings. The Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in ontact with Food noted that the Scientific ommittee on Food (SF) had issued a statement on the use of NOGE as an additive in food contact materials in December Based on the presence of structural alerts for toxic effects, and in the absence of information on exposure and toxicity profile, the SF evaluated as not appropriate the use of NOGE as an additive in organosols for food contact materials (SF, 1999). In a subsequent opinion on bisphenol-f-diglycidyl ether (BFDGE), which can be considered as the lowest molecular weight component of NOGE, the SF noted that NOGE, may give rise to a broader scope of cross-linking reactions compared to BFDGE because NOGE contains oligomers bearing more than 2 epoxy groups. Therefore BFDGE cannot be regarded as a worst case test compound for evaluating the toxicity of NOGE. In 2000, the SF therefore requested mutagenicity studies with the oligomeric fraction of NOGE having a molecular weight lower than 1000 D. onsidering the available evidence of mutagenicity in vitro of BFDGE, and the presence of epoxy groups on NOGE oligomers, the SF concluded that a positive response in the standard genotoxicity tests in vitro could be anticipated. Therefore a package of in vivo assays addressing various end-points and tissues was recommended by the SF in In this opinion the Panel considered three recent in vivo mutagenicity studies carried out with a low molecular weight commercial Epoxy Phenolic Novolac Resin containing high percentages of oligomers with molecular weight below 1000 D and BFDGE. The material
2 was tested in a transgenic rodent system with the analysis of mutations in the liver and the forestomach, in the rat liver unscheduled DNA synthesis (UDS) assay and in the mouse bone marrow micronucleus test. Negative results were obtained in all three studies following the administration of NOGE oligomers and BFDGE up to the highest recommended dose level. Based on the examined data, the Panel concluded that the oligomeric fraction of NOGE with molecular weight below 1000 D and BFDGE are not genotoxic in vivo. onsidering the lack of genotoxicity and the information on specific migration from heavy duty coatings provided by the applicant showing that migration is 50 g/kg food, the Panel concluded that the use of NOGE as a starting substance in heavy duty epoxy coatings is not of concern from a safety point of view. KEY WORDS Epoxy Phenolic Novolac Resin, Novolac Glycidyl Ether, NOGE, AS No and , Bisphenol-F-diglycidyl ether (BFDGE), AS No , PM REF 12976, food contact materials, coatings, genotoxicity. BAKGROUND According to ommission Directive 2002/16/E on the use of certain epoxy derivatives in materials and articles intended to come into contact with foodstuffs NOGE may not be used in materials and articles made of plastics, articles covered by surface coatings or adhesives except for containers and storage tanks having a capacity greater than liters and for pipelines belonging to or connected with them. At the time of the adoption of the Directive information on the toxicological profile and potential exposure to NOGE was not available. Previous evaluations NOGE was first evaluated by the SF in November 1999 during its 119 th meeting. The ommittee had been informed that NOGE was used as alternative to bisphenol A based glycidyl ether (BADGE) as additive in organosols. The ommittee noted that NOGE had structural alerts for toxic effects (i.e. the presence of epoxy groups and the potential for chlorohydrin formation) and that analytical methods for identification and estimation of NOGE and its reaction products were not available. Therefore the ommittee concluded that, in the absence of information on potential exposure and toxicity of NOGE and its reaction products, the use of NOGE as an additive in organosols in food contact materials was not appropriate (SF, 1999). NOGE was again evaluated by the SF during its 123 rd meeting in October 2000, together with bisphenol-f-diglycidyl ether (BFDGE), the lowest molecular weight component of NOGE (SF, 2000). The ommittee noted that NOGE contains oligomers bearing more than 2 epoxy groups which may give rise to a broader scope of cross-linking reactions than 2
3 bis-epoxides like BFDGE, BADGE and BADGE oligomers. Therefore these bisepoxides cannot be considered as worst case test compounds. For this reason, in addition to nontoxicity data according to guidelines, the results of 3 mutagenicity studies on the more representative NOGE fraction having a MW less than 1000 D were requested to be provided within one year. oncerning BFDGE, based on limited non-toxicity data and mutagenicity studies showing positive results in vitro but not in vivo, the compound was provisionally classified by the ommittee in List 7 with the request for absorption, distribution, metabolism and excretion (ADME) and DNA binding studies to be provided within three years (SF, 2000). Industry proposal for the toxicological testing of NOGE Following the adoption of the above mentioned SF opinion, an alternative proposal for the toxicological testing of NOGE was put forward by industry. According to the proposal, standard in vitro mutagenicity tests on NOGE were regarded as of limited utility, because a positive response was anticipated in view of the presence of the in vitro mutagens BFDGE in NOGE. Therefore a transgenic rat mutagenicity study, coupled with a rat micronucleus test for clastogenic and aneugenic effects was proposed (APME, 2002). The proposal was discussed during a hearing with industry held on the occasion of the 93 rd meeting of the SF working group Food ontact Materials on 13 October It was agreed that a low viscosity commercial product (with a ratio 1:1 of BFDGE:oligomeric fraction <1000 D and < 20% with MW above 1000 D) was the preferred test material because it was likely to reflect more the substances which will migrate from the coating. It was recommended by the working group to optimise the dosing to ensure that the fraction of interest reached the doses recommended in guidelines. The working group recommended that all the tests outlined by industry, i.e. a transgenic rodent study, an UDS in vivo/in vitro study, and a micronucleus in vivo study be performed. The WG agreed that ADME and DNA-binding studies were not warranted for NOGE, and could be postponed for BFDGE awaiting the results of the in vivo genotoxicity studies on the mixture (SF, 2002). The above mentioned studies have been performed and forwarded to EFSA for evaluation. TERMS OF REFERENE In accordance with Article 29 (1) (a) of Regulation (E) No. 178/2002 the European Food Safety Authority is asked to carry out risk assessments on substances intended for use in materials in contact with food. In particular, EFSA is asked to advise the ommission on the implications for human health of the use of Epoxy Phenolic Novolac Resins (Novolac Glycidyl Ether, NOGE) as starting substance only for special coatings, called heavy duty coatings, applied to containers having a capacity of more than liters and to pipelines connected to them. 3
4 ASSESSMENT The Panel has given consideration to the data already available on BFDGE and evaluated by the SF, as well as to the new mutagenicity studies with low molecular weight (MW) commercial Epoxy Novolac Resin. hemistry Epoxy Phenolic Novolac Resins (NOGE) are polymeric reaction products of phenol, formaldehyde and epichlorohydrin described by the AS No (Phenolformaldehyde-glycidyl ether) or AS No (phenol-formaldehydeepichlorohydrin polymer). Epoxy Phenolic Novolac Resins are manufactured in two stages: I. reaction of phenol with formaldehyde to yield phenolic novolac resins (mixture of the 2-ring bisphenol F plus components with 3 or more rings) II. reaction of phenolic novolac resins with epichlorohydrin, to form Epoxy Phenolic Novolac Resins or NOGE (mixture of the 2-ring bisphenol-f-diglycidyl ether (BFDGE) plus epoxides with 3 or more aromatic rings and epoxy groups) The lowest molecular weight oligomeric fraction in commercial Epoxy Phenolic Novolac Resins is bisphenol-f diglycidylether. BFDGE exists as a mixture of three isomers with MW of 312 and is present in NOGE at levels of 20 45%. NOGEs have the following general structure: H 2 O H H 2 O O O H 2 H H 2 O H 2 H2 O H2 H H 2 n BFDGE can be considered as an Epoxy Phenolic Novolac Resin with n = 0. If n = 1, three epoxy groups are available, and the MW is 474. With n = 4, there are 6 epoxy groups and the MW is 964. A typical commercial Epoxy Phenolic Novolac Resin has the following oligomeric distribution: n = 0 : ~45% (BFDGE) n = 1: ~20 % n = 2 : ~10 % n = 3 : ~7 % n = 4 : ~5 % n > 4 : ~13 % ( MW > 1000 D) 4
5 Uses in food contact materials Epoxy Phenolic Novolac Resins are used as starting substance in heavy duty epoxy coatings, with the function of crosslinker and polymeric epoxy binder, and in some countries outside the EU as polymeric additive in PV organosol can coatings, with the function of heat stabilizer and Hl scavenger. According to the information provided by industry, the presence of NOGE as an additive in PV organosols has been phased out in the EU since the end of year 2000 (EPE, 2002). Exposure Both Novolacs and BADGE-based resins have been on the market for a long time. From 1997, Novolacs coatings largely replaced those based on BADGE in vinylic organosols (JIG, 1998). The use of epoxy resins as stabilizers in PV-organosols is associated with higher migration levels compared to heavy duty epoxy coatings. In 1997 a survey of Swiss samples of canned oily foods showed levels of 3- and 4-ring NOGE from < 50 g/kg up to 3330 g/kg food (Bronz et al., 1997). As mentioned above, the use of NOGE in PV organosols has been discontinued in the EU, and restricted to heavy duty coatings for containers bigger than liters (EPE, 2002). onsidering a surface to volume ratio of 0.4 dm 2 per kg of food as appropriate for the specific application, migration levels lower or equal to 50 g/kg have been reported in food simulants (EPE, 2001). New toxicological studies (not considered in previous SF evaluations) Three in vivo mutagenicity studies were performed with a sample of commercial Epoxy Phenolic Novolac Resin. The analytical characterisation of the material showed the presence of approximately 45-50% of BFDGE (n=0), % of oligomers with MW (n=1-4), and 1-5% of polymers with MW >1000 D (n>4) (depending on the method of analysis) (Huntsman, 2003). The studies performed were in compliance with Good Laboratory Practice and OED Guidelines; the main findings obtained are summarized below. Epoxy Phenolic Novolac Resin was assayed in the bone marrow micronucleus test in D-1 mice (Whitwell, 2003). The substance was formulated in 1% (w/v) methyl cellulose in water and administered by gavage at the dose of 4000 mg/kg body weight/day once daily on two consecutive days. The administered dose was equivalent to about 2000 mg/kg body weight (maximum recommended dose) of the oligomeric fraction with MW Based on the results of a preliminary toxicity test showing no clinical signs both in males and females, only males (six per group) were treated in the main test. The negative control group received the vehicle alone according to the same treatment schedule. yclophosphamide, dissolved in saline, was given to the positive control group by single intragastric administration. Animals were sacrificed 24 hours after the second (or for positive controls unique) treatment. The incidence of micronuclei was determined by scoring 2000 polychromatic erythrocytes (PEs) per animals. The ratio between poly- and normochromatic erythrocytes (PE/NE) was calculated during the scoring of the first 1000 PEs. The results obtained indicate that NOGE administration was well tolerated, with no animals dying or showing signs of overt toxicity prior to the scheduled sampling time. The 5
6 incidence of micronucleated PEs was similar in mice receiving NOGE or the vehicle alone, whereas a distinct increase of micronucleated PEs was detected in animals belonging to the positive control group. No significant difference in the PE/NE ratio was observed among treatment groups. Epoxy Phenolic Novolac Resin was tested for its ability to induce unscheduled DNA synthesis (UDS) in the livers of male rats dosed via oral gavage using an in vivo/in vitro procedure (Beevers, 2003). In an initial range-finding study, outbred male Han Wistar rl:wi (Glx/BRL/Han) IGS BR rats were dosed once with 4000 mg/kg body weight Epoxy Phenolic Novolac Resin formulated in 1% (w/v) methylcellulose (equivalent to the maximum recommended dose of 2000 mg/kg b.w. for the d oligomeric fraction). During a 2 day post-dose observation period, no significant clinical signs were observed. In the main experiment, groups of three male rats were treated once by gavage with the vehicle or with mg/kg body weight of Epoxy Phenolic Novolac Resin (equivalent to approximately mg/kg body weight of D oligomers). The following positive control substances were administered by the same route to groups of three rats: 75 mg/kg body weight of 2-acetamidofluorene (2-AAF) suspended in corn oil (12-14 hour experiment), and 10 mg/kg body weight of dimethylnitrosamine (DMN) dissolved in purified water (2-4 hour experiment). Approximately hours (Experiment 1) or 2-4 hours (Experiment 2) after dosing, animals were sacrificed and their livers perfused with collagenase to provide a primary culture of hepatocytes. ultures were made from at least three animals in each dose group and were treated with [ 3 H] thymidine. Six slides from each animal were prepared with fixed hepatocytes and examined microscopically after autoradiography. For each animal the net nuclear grain count (NNG), i.e. the number of grains present in the nucleus minus the mean number of grains in an equivalent area of cytoplasm, was determined in one hundred cells from 1-3 slides. Treatments did not produce clinical signs at any time. Mean NNG value in the negative control group was less than zero with no cells in repair. Similarly, negative mean NNG values were observed in animals treated with NOGE, with less than 1% of cells in repair. A distinct increase in NNG (above 10) was observed in animals treated with positive control substances. Epoxy Phenolic Novolac Resin was evaluated for the ability to induce gene mutation in the lacz transgene in tissues from Muta TM Mice (D 2 -lacz80/hazfbrstrain) (Ballantyne, 2004). The Panel noted that this study was conducted in accordance with the newly agreed OED guidelines (OED, 2005). The test substance was formulated in 1% (w/v) methylcellulose (M) in water and administered by gavage at 20 ml/kg body weight. In a preliminary range finding study, three male Muta TM Mice were treated for 7 consecutive days with 4000 mg/kg body weight/day of Epoxy Phenolic Novolac Resin, equivalent to about 2000 mg/kg body weight/day of oligomers with MW No clinical signs of toxicity, and no abnormal organ morphology was observed in any animal at sacrifice. Based on these data, 4000 mg NOGE/kg body weight/day (or 2000 mg/kg body weight/day of oligomers D) was selected as maximum recommended dose for the main study where groups of seven male mice were treated once a day for 28 consecutive days. A lower dose of 2680 mg NOGE/kg body weight/day (approximately 2/3 the maximum dose) was also included in the main study, together with a vehicle control group, dosed with 1% M alone. oncurrent positive controls are not normally necessary in this type of study, but it is recommended that positive control DNA be included to confirm the success of the 6
7 laboratory procedures (Heddle et al., 2000). In this work DNA samples obtained from the liver of mice treated orally with 4-nitroquinoline-1-oxide (200 mg/kg body weight, 24 hours before sacrifice) were processed together with other DNA samples. No compound related clinical signs of toxicity occurred during the course of the treatment period. One animal from each of the high and low dose groups was incorrectly dosed and killed in extremis. All surviving animals were sacrificed and necropsied 3 days after the final administration (Day 31). DNA was extracted from forestomach and liver, aliquots of isolated DNA were then introduced into competent E. coli lac - gale - Kan r (gale - Amp r ) bacteria using a bacteriophage lambda vector. Packaged DNA was absorbed to competent bacteria for approximately 20 minutes, and then plated on titration plates to determine the total number of plaque-forming units (pfu), and plates containing phenylgalactose (P-gal, 0.3% w/v) for the scoring of lacz - mutants, which produce clear plaques on this medium. Mutation frequencies per million (MF) were calculated scoring at least 200,000 plaqueforming units (pfu) per animal, in at least five animals per group, giving a total yield of more than one million pfu analysed per group. MF in liver and forestomach of treated animals were as follows: Treatment Liver a MF x 10-6 Group MF 10-6 (SD) Forestomach a MF x 10-6 Group MF x 10-6 (SD) 1% M Vehicle (19.20) (23.56) Epoxy Phenolic Novolac Resin (fraction D) 1340 mg/kg Epoxy Phenolic Novolac Resin (fraction D) 2000 mg/kg (62.54) (18.68) (35.34) (18.97) a mutation data could not be obtained from some animals due to poor packaging efficiencies, which led to too few analysable pfu; in all cases, however, data from at least five animals per group were available, as indicated in the study protocol. 7
8 Liver and forestomach mean MF (± standard deviation) for the vehicle group (62.83 ± 19.2 and ± 23.6 respectively) were comparable to historical control data (64.25 ± 26.4 and ± 25.9 for liver and stomach, respectively; no data were available for forestomach). MF from positive control DNA was (± , 10 samples). A slight increase in mean mutant frequency was observed in liver samples from animals treated with the low dose of NOGE, and from forestomach samples of animals treated with the high dose. These increases were not statistically significant compared to vehicle control groups (ANOVA and Dunnett s tests on untransformed and rank transformed data) and can be attributed to the variability of data which is typically observed with transgenic mutation assays. Moreover, the larger increase in mutant frequency (observed in liver samples) did not satisfy any of the conditions required for a positive response, i.e. it was not dose related and did not exceed twice the mean historical negative control frequency, nor two standard deviations above the mean historical control(heddle et al., 2000). DISUSSION The newly provided genotoxicity studies on NOGE show that commercial Epoxy Phenolic Novolac Resin (~ 50 % of BFDGE, ~ 50 % oligomers with MW ) did not induce clastogenic or aneugenic effects in the mouse bone marrow micronucleus test, nor unscheduled DNA synthesis, an hallmark of DNA damage and repair, in the liver of rats in vivo. Even though no alteration in the ratio polychromatic/normochromatic erythrocytes was observed in the mouse micronucleus test, the Panel noted that myeologram changes, indicative of toxicity to bone marrow, were observed in a previous general toxicity study in rats with BFGDE, suggesting that the target tissue was exposed to the test material. After repeated oral administration of the same commercial Epoxy Phenolic Novolac Resin, only non-statistically significant increases in mutant frequencies were observed in liver and forestomach of lacz transgenic mice. These results are attributed to the variability of data which is typically observed with transgenic mutation assays, as no one of the conditions required for a positive response by current evaluation criteria, i.e. a relationship with the dose or an increase exceeding twice the mean historical negative control frequency or two standard deviations above the mean historical control, was satisfied. Based on these results, it is concluded NOGE does not induce gene mutations in vivo in the liver nor at the site-ofcontact following oral administration to mice. Overall, the experimental data provided by the studies considered in this opinion show that commercial Epoxy Phenolic Novolac Resin (~ 50 % BFDGE, ~ 50 % of oligomers with MW ) is not genotoxic in vivo. The SF classified BFDGE in List 7, with the request for ADME and DNA binding studies to clarify the systemic availability of orally dosed BFDGE and its potential genotoxicity in vivo. The new studies with commercial Epoxy Phenolic Novolac Resin, which contained ~ 50 % of BFDGE in addition to NOGE oligomers, demonstrate that also BFDGE does not induce genotoxic effects in liver and bone marrow, nor at the site of contact. On this basis, and also considering the evidence of systemic exposure provided by 8
9 the rat sub-chronic toxicity study on BFGDE, it is concluded that BFDGE is not genotoxic in vivo. Therefore the additional studies required by the SF to clarify the systemic availability and in vivo genotoxic potential of BFDGE (i.e. ADME and DNA binding studies) are no longer considered necessary. ONLUSIONS The studies evaluated by the Panel address the reservation expressed by the SF on the genotoxic potential of oligomers of bisphenol F diglycidylether with n 1, raised by the presence of multiple ( 3) epoxy groups. The studies were performed on a commercial, low molecular weight Epoxy Phenolic Novolac Resin (NOGE) containing BFDGE and the oligomeric fraction <1000 D in 1:1 ratio and < 20% with MW above 1000 D. Dosages were adjusted in order to administer the highest recommended dose of both the oligomeric fraction with molecular weight (corresponding to 3- to 6-ring oligomers), and BFGDE (the 2-ring lowest molecular weight component of NOGE). The studies, addressing various end-points and target tissues, show that NOGE is not genotoxic in vivo. onsidering the lack of genotoxicity and the information provided by the applicant on specific migration from heavy duty coatings ( 50 µg/kg), the Panel concluded that the use of NOGE as a starting substance in heavy duty epoxy coatings is not of concern from a safety point of view. The new studies on NOGE evaluated by the Panel provided additional confirmation that BFDGE is not genotoxic in vivo. Therefore the additional studies previously requested by the SF to clarify the genotoxic potential of BFDGE in vivo (ADME and DNA binding) are no longer considered necessary. REFERENES APME, Association of Plastics Manufacturers in Europe (2002), Proposal for the Toxicological Testing of NOGE. APME Epoxy Resins ommittee, March 5, 2002 (S/PM/4005) Ballantyne M. (2004), Epoxy Phenolic Novolac Resin: Induction of lacz mutations in tissues of treated Muta Mice. ovance report n. 1436/71-D6171, April Beevers. (2003), Epoxy Phenolic Novolac Resin: measurement of unscheduled DNA synthesis in rat liver using an in vivo/in vitro procedure. ovance report n 1436/70-D6173, December Bronz M., et al (1997), Diglycidyl ethers of bisphenol-f and Novolac in canned oily foods. Mitt. Giebiet Lebens. Hyg. 88, EPE (2001), Specific migration studies from heavy duty coatings. February EPE (2002). presentation in the course of the hearing with the SF Food contact materials working group, 13 Novembre
10 Heddle, J.A., Dean, S., Nohmi, T., Boerringter, M., asciano, D., Douglas, G.R., Glickman, B., Gorelick, N., Mirsalis, J., Martus, H.J., Skopek, T., Thybaud, V., Tindall, K., Yajima, I. (2000), In vivo transgenic mutation assays. Environ. Mol. Mutagen. 35, Huntsman Advanced Material (2003), Epoxy Novolac Resin (NOGE), Batch n. 0421: Analytical characterisation. Request n. 194/2003, report date JIG, Joint Industry Group Metal Packaging (1998), meeting with SF delegates, Birmingham UK, July OED (2005), Draft Detailed Review Paper on Transgenic Rodent Mutation Assays, Paris, February SF (1999), Minutes statement of the 119th meeting of the Scientific ommittee on Food (1-2 December 1999). Statement on the use of novolac glycidyl ethers (NOGE) as additives in food contact materials, SF (2000), Opinion of the Scientific ommittee on Food on the 11th additional list of monomers and additives for food contact materials (expressed on 19 October 2000), SF (2002), Minutes of the 93 rd meeting of the SF working group Food contact materials, November Whitwell J. (2003), Epoxy Phenolic Novolac Resins: induction of micronuclei in the bone marrow of treated mice. ovance report n 1436/69-D6172. December SIENTIFI PANEL MEMBERS Robert Anton, Sue Barlow, Dimitrios Boskou, Laurence astle, Riccardo rebelli, Wolfgang Dekant, Karl-Heinz Engel, Stephen Forsythe, Werner Grunow, Marina Heinonen, John hr. Larsen, atherine Leclercq, Wim Mennes, Maria Rosaria Milana, Iona Pratt, Ivonne Rietjens, Kettil Svensson, Paul Tobback, Fidel Toldrá. 10
Scientific Opinion on the safety assessment of the substance adipic acid dihydrazide, CAS No , for use in food contact materials 1
EFSA Journal 2015;13(1):3961 SCIENTIFIC OPINION Scientific Opinion on the safety assessment of the substance adipic acid dihydrazide, CAS No 1071-93-8, for use in food contact materials 1 EFSA Panel on
More informationEFSA Guidance on the Submission of a. Evaluation: Toxicological data
Committed since 2002 to ensuring that Europe s food is safe EFSA Guidance on the Submission of a Dossier on Food Enzymes for Safety Evaluation: Toxicological data Prof. Karl-Heinz Engel CEF Panel member
More informationOpinion on Bisphenol A diglycidyl ether (BADGE) (expressed on 24 March 1999)
EURPEAN CMMISSIN DIRECTRATE-GENERAL XXIV CNSUMER PLICY AND CNSUMER HEALTH PRTECTIN Directorate B - Scientific opinions on health matters Unit B3 - Management of scientific committees II SCIENTIFIC CMMITTEE
More informationOfficial Journal of the European Communities
L 51/27 COMMISSION DIRECTIVE 2002/16/EC of 20 February 2002 on the use of certain epoxy derivatives in materials and articles intended to come into contact with foodstuffs (Text with EEA relevance) THE
More informationSERVA DNA Stain Clear G Cat. No
1 SERVA DNA Stain Clear G Cat. No. 39804 1. Introduction Ethidium bromide (EtBr) is most commonly used nucleic acid stain in molecular biology laboratories. It has been proved to be strong carcinogen and
More informationLAWSONE OPINION OF THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS. SCCNFP/0561/02, final.
SCCNFP/0561/02, final OPINION OF THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS CONCERNING LAWSONE Colipa n C146 adopted by the SCCNFP during the 19 th plenary
More informationThree recently approved in vivo genotoxicity test guidelines
Three recently approved in vivo genotoxicity test guidelines (Revised in February 2018) a. Title of the test guideline (year of original adoption, year of update) In Vitro Mammalian Cell Gene Mutation
More informationHDGreen Safe DNA Dye Safety Test Reports
HDGreen Safe DNA Dye Safety Test Reports IDENTIFICATION OF THE PRODUCT AND OF THE COMPANY Product name HDGreen Safe DNA Dye Catalog number ISII-HDGreen Supplier Information in case of emergency Intas Science
More information486 Adopted: 21st July 1997
486 Adopted: 21st July 1997 OECD GUIDELINE FOR THE TESTING OF CHEMICALS Unscheduled DNA Synthesis (UDS) Test with Mammalian Liver Cells In Vivo INTRODUCTION 1. The purpose of the unscheduled DNA synthesis
More informationMidori Green Advance DNA Stain Safety Report
Publishing date: 30.09.2011 Midori Green Advance DNA Stain Safety Report IDENTIFICATION OF THE PRODUCT AND OF THE COMPANY Product name Catalog number Supplier Information in case of emergency Midori Green
More informationSCIENTIFIC OPINION. Genotoxicity Test Strategy for Substances belonging to Subgroups of FGE.19 1
The EFSA Journal (2008) 854, 1-5 SCIENTIFIC OPINION Genotoxicity Test Strategy for Substances belonging to Subgroups of FGE.19 1 Statement of the Panel on Food Contact Materials, Enzymes, Flavourings and
More informationTable 1: Current status of the test guidelines for genetic toxicology
OECD TEST GUIDELINES FOR TESTING OF CHEMICALS: INTRODUCTION TO THE OECD GUIDELINES ON GENETIC TOXICOLOGY TESTING 1. GENERAL INTRODUCTION 1. This Introduction to the Test Guidelines (TG) on genetic toxicology
More informationOpinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request related to
The EFSA Journal (2006) 394, 1-8 Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request related to the safety in use of the
More informationSCIENTIFIC OPINION. EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) 2, 3
EFSA Journal 2014;12(4):3635 Suggested citation: EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids), 2014. Scientific Opinion on the safety assessment of the
More informationScientific Opinion on the safety assessment of the substances, kaolin and polyacrylic acid, sodium salt, for use in food contact materials 1
EFSA Journal 2014;12(4):3637 SCIENTIFIC OPINION Scientific Opinion on the safety assessment of the substances, kaolin and polyacrylic acid, sodium salt, for use in food contact materials 1 ABSTRACT EFSA
More informationTest Report. The Report of Acute Oral Toxicity Test
Test Report Sample No.: 2011KF0435 Test Item: Safe Nucleic Acid Stain Sponsor: Yekta Tajhiz Azma The Report of Acute Oral Toxicity Test Test item: Safe Nucleic Acid Stain Sample No.: 2011KF0435 Subject
More informationMidori Green DNA Stain Safety Test Reports
Midori Green DNA Stain Safety Test Reports IDENTIFICATION OF THE PRODUCT AND OF THE COMPANY Product name Catalog number Supplier Information in case of emergency Midori Green DNA Stain MG01 MG02 Nippon
More informationREQUEST FOR A RE-EVALUATION OF HAIR DYES LISTED IN ANNEX III TO DIRECTIVE 76/768/EEC ON COSMETIC PRODUCTS
OPINION OF THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS CONCERNING REQUEST FOR A RE-EVALUATION OF HAIR DYES LISTED IN ANNEX III TO DIRECTIVE 76/768/EEC ON
More informationThe Comet Assay How to recognise Good Data
The Comet Assay How to recognise Good Data William Barfield 4 th September 2015 ICAW Content Regulatory Genetic Toxicology JaCVAM trial overview and results Protocols Historical control data Statistics
More informationGlyphosate Research Scoping
Glyphosate Research Scoping Stephanie L. Smith-Roe, Ph.D. Biomolecular Screening Branch National Institute of Environmental Health Sciences NTP Board of Scientific Counselors Meeting June 15 16, 2016 Glyphosate
More informationPROPOSAL THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS
THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS PROPOSAL FOR A STRATEGY FOR TESTING HAIR DYE COSMETIC INGREDIENTS FOR THEIR POTENTIAL GENOTOXICITY/MUTAGENICITY
More informationSCIENTIFIC OPINION. EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) 2,3
EFSA Journal 2015;13(2):4008 SCIENTIFIC OPINION Scientific Opinion on the safety assessment of the substance (methacrylic acid, ethyl acrylate, n-butyl acrylate, methyl methacrylate and butadiene) copolymer
More information11 th International Conference on Environmental Mutagens Foz du Iguaccu, Brazil; 7 November 2013
Pig-a In Vivo Mutation Assay Workgroup Report 6 th International Workshop on Genotoxicity Testing Presented By: Bhaskar Gollapudi, Ph.D. Exponent, Inc. 11 th International Conference on Environmental Mutagens
More information06/03/2009. Overview. Preclinical Support for Exploratory Phase I Clinical Trials. Micro-dosing IND. Pharmacological Active Single Dose IND
Preclinical Support for Exploratory Phase I Clinical Trials Clive Joseph, DSRD Sandwich Overview Identify the most appropriate development paradigm - traditional vs alternative IND approach Confidence
More information, E C H A 1(25) Helsinki, 19 May 2017
, E C H A 1(25) Helsinki, 19 May 2017 Registered substance name: reaction product: bisphenol-a-(epichlorhydrin); epoxy resin (number average molecular weight 700) EC No: 500-033-5 CAS No: 25068-38-6 Date
More informationReplaced. effectively on 26 January 2015.
OECD/OCDE 488 Adopted: 28 July 2011 OECD GUIDELINE FOR THE TESTING OF CHEMICALS Transgenic Rodent Somatic and Germ Cell Gene Mutation Assays INTRODUCTION 1. OECD Test Guidelines (TGs) are available for
More informationCoatings in NL. Regulation and risk assessment of Coating as FCM in The Netherlands. Bianca van de Ven RIVM
Coatings in NL Regulation and risk assessment of Coating as FCM in The Netherlands Bianca van de Ven RIVM Content 1. Regulation of FCM in NL - General provisions - Coating specific provisions 2. Substance
More informationStructure and content of an IMPD. What is required for first into man trial?
What is required for first into man? The EU IMPD Thomas Sudhop, MD Scope Structure and content of an IMPD What is required for first into man trial? Only for IMPs that do not have a marketing authorisation
More informationToxicology Testing. Genetic Toxicology Service List Comprehensive
Toxicology Testing Genetic Toxicology Service List Comprehensive Table of Contents Preface Page Regulatory Guidelines 1 Assay Details Section Color Code Page GLP In Vitro Assays 2 GLP In Vivo Assays 7
More informationScientific Opinion on the safety evaluation of the process Sky-Light MPR, used to recycle post-consumer PET into food contact materials 1
EFSA Journal 2013;11(11):3450 SCIENTIFIC OPINION Scientific Opinion on the safety evaluation of the process Sky-Light MPR, used to recycle post-consumer PET into food contact materials 1 ABSTRACT EFSA
More informationOur Business. in vitro / in vivo. in vitro / in vivo ADME. in vitro / in vivo. Toxicology. Cell Battery V79. Analytical Services. Service.
GenPharmTox is one of the few CROs who can guarantee the success of our project within the given time framework and on the terms agreed. Dr. Michael Runkel, Apogepha GmbH 3 3 In vitro 3.1. Phototoxicity
More informationTesting Methods and Directives
EUROPEAN COMMISSION DIRECTORATE GENERAL - JRC JOINT RESEARCH CENTRE Institute for Health and Consumer Protection Unit: Toxicology and Chemical Substances European Chemicals Bureau D:\My Documents\JR\Tables\OFFJOUR\Listofoj.doc
More informationReport No. 38 EPOXYRESINS. June A private report by the PROCESS ECONOMICS PROGRAM STANFORD RESEARCH INSTITUTE MENLO PARK, CALIFORNIA
Report No. 38 EPOXYRESINS by ROBERT G. MULLER June 1968 A private report by the PROCESS ECONOMICS PROGRAM STANFORD RESEARCH INSTITUTE MENLO PARK, CALIFORNIA CONTENTS 1 INTRODUCTION... 1 2 SUMMARY.........................
More informationMedical Device Testing. Andrew Makin, MSc, ERT, MRSB Scientific Director CiToxLAB Scantox, Denmark
Medical Device Testing Andrew Makin, MSc, ERT, MRSB Scientific Director CiToxLAB Scantox, Denmark Medical device Risk evaluation Efficacy Biocompatibility Clinical testing Pharmaceutical product Preclinical
More informationPreclinical studies needed in the development of human pharmaceutical drugs role of toxicology and risk assessment
Preclinical studies needed in the development of human pharmaceutical drugs role of toxicology and risk assessment Hubert Dirven Lead Validation Unit - NPI Amersham Health (GE Healthcare), Oslo Preclinical
More informationPre-Clinical Evaluation of ALN-AAT to Ameliorate Liver Disease Associated with Alpha-1 Antitrypsin Deficiency
Pre-Clinical Evaluation of ALN-AAT to Ameliorate Liver Disease Associated with Alpha-1 Antitrypsin Deficiency A. Sehgal 1, K. Blomenkamp 2, K Qian 1, A. Simon 1, P. Haslett, S. Barros 1, J. Teckman 2 May
More informationHygienic evaluation of materials for the production of elastomers in contact with drinking water
Gummi Fasern Kunststoffe, 67, No. 11, 2014, pp. 697 701 Hygienic evaluation of materials for the production of elastomers in contact with drinking water R. Schuster Federal Environment Agency, Section
More informationSUPPLEMENTARY INFORMATION
In format provided by Orchard et al. (SEPTEMBER 2011) Supplementary information S1 Sample MIABE file exemplifying data extracted from PMID: 20568778 Responsible Person or Role Contact Person Bryan K. S.
More informationUPDATED RECOMMENDED STRATEGY TESTING HAIR DYES FOR THEIR POTENTIAL GENOTOXICITY/MUTAGENICITY/CARCINOGENICITY
THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS UPDATED RECOMMENDED STRATEGY FOR TESTING HAIR DYES FOR THEIR POTENTIAL GENOTOXICITY/MUTAGENICITY/CARCINOGENICITY
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Seite 1 von 6 Inspections, Compliance, Enforcement, and Criminal Investigations Sitek Research Laboratories 5/21/09 Department of Health and Human Services Public Health Service Food and Drug Administration
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) POSITION PAPER ON NON-CLINICAL SAFETY STUDIES TO SUPPORT CLINICAL TRIALS WITH A SINGLE MICRODOSE
European Medicines Agency Evaluation of Medicines for Human Use London, 23 June 2004 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) POSITION PAPER ON NON-CLINICAL SAFETY STUDIES TO SUPPORT CLINICAL
More informationToxicology Letters. DNA-repair-deficient Rad54/Rad54B mice are more sensitive to clastogens than wild-type mice
Toxicology Letters 183 (2008) 112 117 Contents lists available at ScienceDirect Toxicology Letters journal homepage: www.elsevier.com/locate/toxlet DNA-repair-deficient Rad54/Rad54B mice are more sensitive
More informationGuideline on assessment and control of DNA reactive (mutagenic) impurities in veterinary medicinal products
1 2 3 24 February 2017 EMA/CVMP/SWP/377245/2016 Committee for Medicinal Products for Veterinary Use (CVMP) 4 5 6 Guideline on assessment and control of DNA reactive (mutagenic) impurities in veterinary
More informationGenotoxicity testing strategies: updated recommendations for the assessment of pesticides Riccardo Crebelli
New Pesticide Regulation: Innovative Aspects and Emerging Problems October 5, 2010 Aula Pocchiari - Istituto Superiore di Sanità Viale Regina Elena, 299 ROMA Genotoxicity testing strategies: updated recommendations
More informationAPPENDIX IV OECD GUIDELINES FOR TESTING OF CHEMICALS. 1- The OECD Test Guidelines submission and adoption process
APPENDIX IV OECD GUIDELINES FOR TESTING OF CHEMICALS 1- The OECD Test Guidelines submission and adoption process The OECD Test Guidelines Programme provides the mechanism for developing new Test Guidelines,
More informationBasic principles of the safety assessment of drugs
Basic principles of the safety assessment of drugs SFT Annual meeting 2013 Björn Dahl, PhD Senior Project Director Global Safety Assessment AstraZeneca R&D Outline of presentation Safety assessment in
More informationSafety assessment of the substance Ln 1,4-benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials
SCIENTIFIC OPINION ADOPTED: 26 September 2018 doi: 10.2903/j.efsa.2018.5449 Safety assessment of the substance Ln 1,4-benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials
More informationMB Expands Capabilities Adds Ames Test, MTD and Range Finding
What's New @ MB? MB Expands Capabilities - Ames, PK, MTD, Range Finding New! - PorCORA - Non-Animal Ocular Irritation/Reversibility Test Under Development - PorFocal - Low-Level Ocular Irritation Screening
More informationNote for Guidance for Food Contact Materials. European Food Safety Authority FOOD CONTACT MATERIALS NOTE FOR GUIDANCE
European Food Safety Authority FOOD CONTACT MATERIALS NOTE FOR GUIDANCE ("NOTE FOR GUIDANCE FOR PETITIONERS PRESENTING AN APPLICATION FOR THE SAFETY ASSESSMENT OF A SUBSTANCE TO BE USED IN FOOD CONTACT
More informationOPINION ON AN ADDITIONAL LIST OF MONOMERS AND ADDITIVES FOR FOOD CONTACT MATERIALS
EUROPEAN COMMISSION DIRECTORATE-GENERAL XXIV CONSUMER POLICY AND CONSUMER HEALTH PROTECTION Directorate B - Scientific opinions on health matters Unit B3 - Management of scientific committees II SCIENTIFIC
More informationGuidelines and criteria for seeking approval to conduct clinical trials in Ayurveda, Siddha and Unani system.
Guidelines and criteria for seeking approval to conduct clinical trials in Ayurveda, Siddha and Unani system. Application for seeking approval of the Central Government for conduct of clinical trial in
More information**MATERIAL SAFETY DATA SHEET**
Date Issued: August 19, 2009 Version: 5.0 Supersedes: August 8, 2006 Page 1 of 5 Section 1 Product and Company Identification Product Name: Herceptin Chemical Name: Anti-p185 HER2 Chemical Family: High
More information--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB15193.
Translated English of Chinese Standard: GB15193.1-2003 www.chinesestandard.net Sales@ChineseStandard.net NATIONAL STANDARD OF THE GB PEOPLE S REPUBLIC OF CHINA ICS 07.100 C 53 Replacing GB 15193.1-1994
More informationONAMER M. PRESERVATIVE and ANTIMICROBIAL ONAMER
ONAMER M PRESERVATIVE and ANTIMICROBIAL ONAMER M Stepan Lipid Nutrition is a division of Stepan Company which manufactures lipid and polymer based ingredients. HO OH SUMMARY Our quaternary ammonium polymer
More informationStudies of the Toxicological Potential of Capsinoids VI: Single Dose Toxicity Study and Micronucleus Test of Commercial
Studies of the Toxicological Potential of Capsinoids VI: Single Dose Toxicity Study and Micronucleus Test of Commercial Grade Dihydrocapsiate Eri Watanabe Terutaka Kodama Takeshi Masuyama Shoji Tsubuku
More informationDrug Development / Testing
Drug Development / Testing Preclinical Studies Pharmacological profiling in vitro ex vivo in vivo Toxicology The Blurring Line Between Discovery, Pharmacology, and Preclinics Originally, Discovery meant
More informationCOMMISSION DIRECTIVE 2009/120/EC
15.9.2009 Official Journal of the European Union L 242/3 DIRECTIVES COMMISSION DIRECTIVE 2009/120/EC of 14 September 2009 amending Directive 2001/83/EC of the European Parliament and of the Council on
More informationTanja Krainz Current Literature July 9 th, 2016
Discovery and Characterization of BMN673 (Talazoparib), a Novel, Highly Potent, and Orally Efficacious Poly(ADP-ribose) Polymerase-1,2 Inhibitor, as an Anticancer Agent Wang, B.; Chu, D.; Feng, Y.; Shen,
More informationFrom Drug Discovery to IND Saving Time and Money Through Smart Study Design
From Drug Discovery to IND Saving Time and Money Through Smart Study Design Stephen Madden BSc PhD CBiol FSB Head, Metabolism and Pharmacokinetics Charles River Preclinical Services, Edinburgh Outline
More informationNOTE FOR GUIDANCE FOR THE PREPARATION OF AN APPLICATION FOR THE SAFETY ASSESSMENT OF A SUBSTANCE TO BE USED IN PLASTIC FOOD CONTACT MATERIALS
GUIDANCE ADOPTED: 31 July 2008 UPDATED: 23 March 2017 doi: 10.2903/j.efsa.2008.21r NOTE FOR GUIDANCE FOR THE PREPARATION OF AN APPLICATION FOR THE SAFETY ASSESSMENT OF A SUBSTANCE TO BE USED IN PLASTIC
More informationS9 Nonclinical Evaluation for Anticancer Pharmaceuticals
S9 Nonclinical Evaluation for Anticancer Pharmaceuticals This draft guidance, when finalized, will represent the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create
More informationSCIENTIFIC OPINION. EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) 2,3
EFSA Journal 2012;10(10):2907 SCIENTIFIC OPINION Scientific Opinion on the safety evaluation of the following processes based on VACUREMA Prime technology used to recycle post-consumer PET into food contact
More informationJoint safety evaluation of substances in printing inks by Germany (BfR) and Switzerland (FSVO)
Federal Department of Home Affairs FDHA Federal Food Safety and Veterinary Office FSVO Risk Assessment Division Joint safety evaluation of substances in printing inks by Germany (BfR) and Switzerland (FSVO)
More informationAccording to BPR Article 19 and Annex II, information on analytical methods is required
Date of draft: 1 (5) Definition of relevant impurities Introduction ECHA is currently working on a revision of the Guidance on Technical Equivalence a (TE Guidance). Among other things, it is necessary
More informationCOMMISSION IMPLEMENTING DECISION. of
EUROPEAN COMMSSON Brussels, 7.9.2015 C(2015) 6030 final COMMSSON MPLEMTNG DECSON of 7.9.2015 on the evaluation of the substance polyhaloalkene pursuant to Article 46(1) of Regulation (EC) No 1907/2006
More informationSafety Report of EvaGreen Dye
Safety Report of EvaGreen Dye A Summary of Mutagenicity and Environmental Safety Test Results from Three Independent Laboratories Glowing Products for Science TM Last updated: March 7, 2011 Overview Real-time
More informationMATERIAL SAFETY DATA SHEET
MATERIAL SAFETY DATA SHEET JANA Jubail Chemical Industries Company P.O.Box - 10661 Jubail Industrial City -31961 Kingdom Of Saudi Arabia Emergency Phone: 00966-3-3585002 Fax : 00966-3-3583192 Effective
More informationBilateral technical meeting between the EFSA Panel on Genetically Modified Organisms and AFSSA
Bilateral technical meeting between the EFSA Panel on Genetically Modified Organisms and AFSSA AFSSA-EFSA Milan 10 december 2008 AFSSA working group on 2000 2000: Working group establishing GMO risk assessment
More informationCOMMISSION REGULATION (EU) / of
EUROPEAN COMMISSION Brussels, 3.12.2018 C(2018) 7942 final COMMISSION REGULATION (EU) / of 3.12.2018 amending Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration,
More informationProduct Safety Summary
Product Safety Summary Phenol, 2,6-bis-(1,1-dimethylethyl)- This product safety summary is intended to provide a general overview of the chemical substance. The information on the Summary is basic information
More informationNMR in Drug Metabolism Extraction NMR - Keeping up with the Pace of Drug Discovery. Dr Ute Gerhard
F NMR in Drug Metabolism Extraction NMR - Keeping up with the Pace of Drug Discovery Dr Ute Gerhard The Early Days Eat plant Feel Worse Feel Better Try again Drug! The Golden Age Make molecule Feed to
More informationAmes Data Submissions and Other Qualification Data for Impurities in Drug Substances
Ames Data Submissions and Other Qualification Data for Impurities in Drug Substances Mark W. Powley, Ph.D. Pharmacologist FDA/CDER/Office of New Drugs Outline Regulatory Background Ames Assay ICH M7 Submission
More informationOECD/OCDE Adopted: 29 July 2016
Adopted: 29 July 2016 OECD GUIDELINE FOR THE TESTING OF CHEMICALS Mammalian Bone Marrow Chromosomal Aberration Test INTRODUCTION 1. The OECD Guidelines for the Testing of Chemicals are periodically reviewed
More informationProduct Safety Summary
Product Safety Summary Phenol, 2-(1-methylpropyl)- This product safety summary is intended to provide a general overview of the chemical substance. The information on the Summary is basic information and
More informationGuidance on Information Requirements and Chemical Safety Assessment. Chapter R.7a: Endpoint specific guidance
1 GUIDANCE Guidance on Information Requirements and Chemical Safety Assessment Chapter R.7a: Endpoint specific guidance Version 3.0 August 2014 NOTE Please note that the present document is a proposed
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE NON-CLINICAL DEVELOPMENT OF FIXED COMBINATIONS OF MEDICINAL PRODUCTS
European Medicines Agency London, 24 January 2008 Doc. Ref. EMEA/CHMP/SWP/258498/2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE NON-CLINICAL DEVELOPMENT OF FIXED COMBINATIONS
More informationCommitted since 2002 to ensuring that Europe s food is safe. David Gott. Chair & Rapporteur - WG Guidance on Food Additives
Committed since 2002 to ensuring that Europe s food is safe Risk assessment paradigm David Gott Vice-chair chair of the ANS Panel Chair & Rapporteur - WG Guidance on Food Additives Stakeholders workshop
More informationPrinting inks for food packaging materials. D. MANTIS Druckfarben HELLAS
Printing inks for food packaging materials D. MANTIS Druckfarben HELLAS Current EC regulations Regulation 2011/10 On plastic materials and articles intended to come into contact with food - Plastic materials
More informationTOXIKON FINAL GLP REPORT: G4 MOUSE LYMPHOMA MUTAGENESIS ASSAY OECD. Test Substance OIS Author Devaki Sadhu, Ph.D.
TOXIKON FINAL GLP REPORT: 08-1144-G4 MOUSE LYMPHOMA MUTAGENESIS ASSAY OECD Test Substance OIS 1220 Author Devaki Sadhu, Ph.D. Final Report Date June 6, 2008 COMPLIANCE OECD Series on Principles of Good
More informationSCIENTIFIC OPINION. EFSA Panel on food contact materials, enzymes, flavourings and processing aids (CEF) 2,3
EFSA Journal 2011;9(7):2184 SCIENTIFIC OPINION Scientific Opinion on the criteria to be used for safety evaluation of a mechanical recycling process to produce recycled PET intended to be used for manufacture
More informationSAFETY DATA SHEET. Non-hazardous in accordance with international standards for workplace safety
Section 1: Identification Product information Product Name Active substance Intended Uses Company Details SAFETY DATA SHEET Torsemide Tablets 5 mg, 10 mg, 20 mg and 100 mg Torsemide Torsemide Tablet is
More informationPrinted paper and board: Priority setting strategy for toxicological assessment
Printed paper and board: Priority setting strategy for toxicological assessment M. Van Bossuyt 1,2, E. Van Hoeck 1, T. Vanhaecke 2, V. Rogiers 2* and B. Mertens 1* 1 Food, Medicines and Consumer Safety,
More informationMAINTENANCE OF THE ICH GUIDELINE ON NON-CLINICAL SAFETY STUDIES FOR THE CONDUCT OF HUMAN CLINICAL TRIALS FOR PHARMACEUTICALS M3(R1)
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE MAINTENANCE OF THE ICH GUIDELINE ON NON-CLINICAL
More informationBiology 137 Introduction to Toxicology Fall Which of the following would enhance the excretion of xenobiotic molecules?
1. Which of the following would enhance the excretion of xenobiotic molecules? A) removal of hydroxyl groups and replacement with hydrogen B) increased hydrophobicity of the molecule, which would allow
More informationSafety Report for EvaGreen dye
Safety Report for dye A summary of mutagenicity and environmental safety test results from three independent laboratories www.biotium.com General Inquiries: order@biotium.com Technical Support: techsupport@biotium.com
More informationProgress and Future Directions in Integrated Systems Toxicology. Mary McBride Agilent Technologies
Progress and Future Directions in Integrated Systems Toxicology Mary McBride Agilent Technologies 1 Toxicity testing tools of the late 20 th century Patchwork approach to testing dates back to the 1930
More informationColorants in Medical Devices:
Colorants in Medical Devices: The Spectrum of Current Regulatory Expectations John Iannone Program Manager/ Technical Specialist Overview» Company Introduction» Why use Colorants in Devices?» Regulatory
More informationSWISS ORDINANCE ON MATERIALS AND ARTICLES IN CONTACT WITH FOOD (SR ) Permitted Substances for Packaging Inks. Questions & Answers
SWISS ORDINANCE ON MATERIALS AND ARTICLES IN CONTACT WITH FOOD (SR 817.023.21) Permitted Substances for Packaging Inks Questions & Answers Page 1 of 5 The Swiss Federal Department of Home Affairs (FDHA)
More informationWorkshop on Food Contact Material legislation in the EU
Workshop on Food Contact Material legislation in the EU Bangkok, Thailand, 1 st November 2007 Compliance with legislation Rinus Rijk 1 Scope Legal requirements: Framework Regulation Plastics Directive
More informationTechnical Notes for Guidance. on the assessment of technical equivalence of substances regulated under Directive 98/8/EC
Technical Notes for Guidance on the assessment of technical equivalence of substances regulated under Directive 98/8/EC These Technical Notes for Guidance were adopted during the 29 th meeting of representatives
More informationSummary of Mutagenic Toxicity Test Results for EvaGreen
Summary of Mutagenic Toxicity Test Results for EvaGreen Compiled by Biotium, Inc. from the results of an independent testing service: Litron Laboratories, Inc., Rochester, NY Overview When our scientists
More informationOECD/OCDE OECD GUIDELINE FOR THE TESTING OF CHEMICALS. In Vivo Mammalian Alkaline Comet Assay
Adopted: 29 July 2016 OECD GUIDELINE FOR THE TESTING OF CHEMICALS In Vivo Mammalian Alkaline Comet Assay INTRODUCTION 1. The in vivo alkaline comet (single cell gel electrophoresis) assay (hereafter called
More informationM7 Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk
M7 Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk This draft guidance, when finalized, will represent the Food and Drug Administration's
More informationLightweight Polymer Aluminum Reinforced Stone Panels
Name Lightweight Polymer Aluminum Reinforced Stone Panels Product ID Terracore PA Classification 04 42 26.00 Masonry (concrete block/brick): Grid-System- Supported Stone Cladding Website www.terracorepanels.com
More informationExploratory IND: a study proposal from Novartis
Exploratory IND: a study proposal from Novartis Rossella Belleli ECD BIOS Novartis 17 Nov 005 Presentation outline What is an exploratory (exp)ind compared to a traditional IND Introduction to traditional
More informationComments and suggestions from reviewer
Comments and suggestions from reviewer Page 1 of 13 Title: WHO Guidelines on the Quality, Safety, and Efficacy of Biological Medicinal Products Prepared by Recombinant DNA Technology: WHO/rDNA_DRAFT/12
More informationPART B: METHODS FOR THE DETERMINATION OF TOXICITY AND OTHER HEALTH EFFECTS GENERAL INTRODUCTION: PART B A. EXPLANATORY NOTE For the purposes of the
PART B: METHODS FOR THE DETERMINATION OF TOXICITY AND OTHER HEALTH EFFECTS GENERAL INTRODUCTION: PART B A. EXPLANATORY NOTE For the purposes of the General Introduction, the following numbering applies:
More informationAgencia Española de Medicamentos y Productos Sanitarios C/Campezo 1, Edificio Madrid España (Reference Member State)
DEPARTAMENTO DE MEDICAMENTOS VETERINARIOS Medicamentos y Productos C/Campezo 1, Edificio 8 28022 Madrid España (Reference Member State) MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT
More informationKit Components and Reagents
A Users Guide Kit Components and Reagents The SOS ChromoTest TM is a test developed for the detection of genotoxicmaterials that cause damage to a cell s DNA. Developed to test for the presence of genotoxicmaterials
More information